ACRIN 6698 trial Quantitative diffusion-weighted MRI to predict pathologic response in neoadjuvant chemotherapy treatment of breast cancer.

被引：1
|
作者：
Partridge, Savannah C.
Zhang, Zheng
Newitt, David C.
Gibbs, Jessica E.
Chenevert, Thomas L.
Rosen, Mark Alan
Bolan, Patrick J.
Marques, Helga
Esserman, Laura
Hylton, Nola M.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11520
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11520
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial
    Partridge, Savannah C.
    Zhang, Zheng
    Newitt, David C.
    Gibbs, Jessica E.
    Chenevert, Thomas L.
    Rosen, Mark A.
    Bolan, Patrick J.
    Marques, Helga S.
    Romanoff, Justin
    Cimino, Lisa
    Joe, Bonnie N.
    Umphrey, Heidi R.
    Ojeda-Fournier, Haydee
    Dogan, Basak
    Oh, Karen
    Abe, Hiroyuki
    Drukteinis, Jennifer S.
    Esserman, Laura J.
    Hylton, Nola M.
    RADIOLOGY, 2018, 289 (03) : 618 - 627
  • [2] Diffusion-weighted MRI findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial
    Krome, Susanne
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2019, 191 (07): : 608 - 608
  • [3] Assessment of diffusion-weighted MRI in predicting response to neoadjuvant chemotherapy in breast cancer patients
    Nathalie A. Hottat
    Dominique A. Badr
    Sophie Lecomte
    Tatiana Besse-Hammer
    Jacques C. Jani
    Mieke M. Cannie
    Scientific Reports, 13 (1)
  • [4] Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer
    Raphael Richard
    Isabelle Thomassin
    Marion Chapellier
    Aurélie Scemama
    Patricia de Cremoux
    Mariana Varna
    Sylvie Giacchetti
    Marc Espié
    Eric de Kerviler
    Cedric de Bazelaire
    European Radiology, 2013, 23 : 2420 - 2431
  • [5] Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer
    Richard, Raphael
    Thomassin, Isabelle
    Chapellier, Marion
    Scemama, Aurelie
    de Cremoux, Patricia
    Varna, Mariana
    Giacchetti, Sylvie
    Espie, Marc
    de Kerviler, Eric
    de Bazelaire, Cedric
    EUROPEAN RADIOLOGY, 2013, 23 (09) : 2420 - 2431
  • [6] Assessment of diffusion-weighted MRI in predicting response to neoadjuvant chemotherapy in breast cancer patients
    Hottat, Nathalie A.
    Badr, Dominique A.
    Lecomte, Sophie
    Besse-Hammer, Tatiana
    Jani, Jacques C.
    Cannie, Mieke M.
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [7] Diffusion-Weighted MRI in Predicting the Efficacy of Neoadjuvant Chemotherapy of Breast Cancer
    Wu, J.
    Shen, K.
    Chen, X.
    Chen, C.
    Hu, Z.
    Liu, G.
    Di, G.
    Lu, J.
    Wu, J.
    Shao, Z.
    Shen, Z.
    CANCER RESEARCH, 2009, 69 (24) : 714S - 715S
  • [8] Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer
    Kim, Yunju
    Kim, Sung Hun
    Lee, Hye Won
    Song, Byung Joo
    Kang, Bong Joo
    Lee, Ahwon
    Nam, Yoonho
    MAGNETIC RESONANCE IMAGING, 2018, 48 : 27 - 33
  • [9] Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS
    Shin, Hee Jung
    Baek, Hyeon-Man
    Ahn, Jin-Hee
    Baek, Seunghee
    Kim, Hyunji
    Cha, Joo Hee
    Kim, Hak Hee
    NMR IN BIOMEDICINE, 2012, 25 (12) : 1349 - 1359
  • [10] Diffusion-weighted MRI for prediction of pathologic complete response in HER2-breast cancer treated with pembrolizumab plus neoadjuvant chemotherapy
    Li, Wen
    Le, Nu N.
    Onishi, Natsuko
    Newitt, David C.
    Gibbs, Jessica E.
    Wilmes, Lisa J.
    Kornak, John
    Partridge, Savannah C.
    LeStage, Barbara
    Price, Elissa R.
    Joe, Bonnie N.
    Esserman, Laura J.
    Hylton, Nola M.
    CANCER RESEARCH, 2022, 82 (04)
12345